CClinicalTrials.gg
CompletedNCT05909605Updated Dec 5, 2023

Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor

An observational study in Feasibility Study and Medical Device, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-05.

Sponsored by University of California, San Diego · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.

02

Conditions studied

  • Feasibility Study
  • Medical Device
03

In context

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants without any severe cardiac anomalies

Inclusion criteria

  • Are able to provide informed consent
  • Have at least one arm

Exclusion criteria

Exclusion Criteria:

  • Active cardiac arrhythmias
  • Any other unstable, active medical condition (i.e., cardiac arrythmia, uncontrolled diabetes, active heart failure, active liver failure)
  • Currently pregnant (this will be confirmed with a urine pregnancy test in women of childbearing potential)
  • Any large movements of the arms (e.g., chorea, dyskinesias, ballism), that in the investigators' opinion, would make it difficult to measure blood pressure using a standard blood pressure cuff
  • Any active skin infection or wound on the arm that would interfere with the devices used to measure blood pressure
  • Diagnosis of dementia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Patient registry
No

Groups and cohorts

  • Ultrasound blood pressure sensor

    Device: sphygmomanometer · Device: Arterial Line

Interventions

  • Devicesphygmomanometer

    Comparison to the ultrasound sensor

  • DeviceArterial Line

    Comparison to the ultrasound sensor

06

What researchers measure

Primary outcomes

  1. Device comparison to standard monitoring (Sphygmomanometer)

    Clinical feasibility of the calibration accuracy of the non-invasive ultrasound blood pressure sensor in comparison to a sphygmomanometer on 10 participants.

    Time frame: 2 years

  2. Device comparison to standard monitoring (A-line)

    Clinical feasibility of the ultrasound blood pressure sensor for monitoring trend changes for continuous 12 hours of measurement in comparison to an arterial line in the Intensive Care Unit on 10 participants.

    Time frame: 2 years

  3. Device comparison to standard monitoring (A-line)

    Clinical feasibility of the ultrasound blood pressure sensor in comparison to an arterial line in the catheterization laboratory on 40 participants.

    Time frame: 3 years

  4. Device comparison to standard monitoring (Sphygmomanometer)

    Clinical feasibility of the device accuracy of the non-invasive ultrasound blood pressure sensor in comparison to a sphygmomanometer on 90 participants in consulting room on orthostatic hypotension participants.

    Time frame: 4 years

07

Study locations

1 site
  • UCSD
    La Jolla, California 92093, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05909605
Lead sponsor
University of California, San Diego
Responsible party
Sheng Xu (Associate Professor, University of California, San Diego) — Principal investigator
First posted
Jun 18, 2023
Start date
Oct 20, 2020
Primary completion
Dec 1, 2023
Completion
Dec 2, 2023
Last update
Dec 5, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion